메뉴 건너뛰기




Volumn 13, Issue 3, 2010, Pages 378-390

Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patients

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; C REACTIVE PROTEIN; EXENDIN 4; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NATEGLINIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PIOGLITAZONE; PLACEBO; REPAGLINIDE; RESISTIN; RETINOL BINDING PROTEIN 4; ROSIGLITAZONE; SIBUTRAMINE; SITAGLIPTIN; TRIACYLGLYCEROL; VILDAGLIPTIN;

EID: 78650335726     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: 10.18433/j3388p     Document Type: Article
Times cited : (13)

References (47)
  • 1
    • 33845914986 scopus 로고    scopus 로고
    • Mechanisms linking obesity with cardiovascular disease
    • Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875-880.
    • (2006) Nature , vol.444 , pp. 875-880
    • van Gaal, L.F.1    Mertens, I.L.2    de Block, C.E.3
  • 3
    • 1042279540 scopus 로고    scopus 로고
    • Physical Activity/Exercise and Diabetes
    • American Diabetes Association
    • American Diabetes Association. Physical Activity/Exercise and Diabetes. Diabetes Care 2004; 27: 58-62.
    • (2004) Diabetes Care , vol.27 , pp. 58-62
  • 4
    • 33846921614 scopus 로고    scopus 로고
    • Weight management for type 2 diabetes mellitus: Global cardiovascular risk reduction
    • Lee M, Aronne LJ. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction. Am J Cardiol 2007; 99: 68B-79B.
    • (2007) Am J Cardiol , vol.99
    • Lee, M.1    Aronne, L.J.2
  • 6
    • 33845874637 scopus 로고    scopus 로고
    • Drug treatments for obesity: Orlistat, sibutramine, and rimonabant
    • Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007; 369: 71-77.
    • (2007) Lancet , vol.369 , pp. 71-77
    • Padwal, R.S.1    Majumdar, S.R.2
  • 7
    • 2342453289 scopus 로고    scopus 로고
    • The efficacy and safety of sibutramine for weight loss: A systematic review
    • Arterburn DE, Crane PK, Veenstra DL. The efficacy and safety of sibutramine for weight loss: a systematic review. Arch Intern Med 2004; 164: 994-1003.
    • (2004) Arch Intern Med , vol.164 , pp. 994-1003
    • Arterburn, D.E.1    Crane, P.K.2    Veenstra, D.L.3
  • 8
    • 0034516930 scopus 로고    scopus 로고
    • Effect of sibutramine on weight maintenance after weight loss: A randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance
    • James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rössner S, Saris WH, Van Gaal LF. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356: 2119-2125.
    • (2000) Lancet , vol.356 , pp. 2119-2125
    • James, W.P.1    Astrup, A.2    Finer, N.3    Hilsted, J.4    Kopelman, P.5    Rössner, S.6    Saris, W.H.7    van Gaal, L.F.8
  • 10
    • 0034520443 scopus 로고    scopus 로고
    • Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: A randomised, double-blind, placebocontrolled study
    • Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebocontrolled study. Diabetes Obes Metab 2000; 2: 105-112.
    • (2000) Diabetes Obes Metab , vol.2 , pp. 105-112
    • Finer, N.1    Bloom, S.R.2    Frost, G.S.3    Banks, L.M.4    Griffiths, J.5
  • 11
    • 33646002321 scopus 로고    scopus 로고
    • Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients
    • Finer N, Ryan DH, Renz CL, Hewkin AC. Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients. Diabetes Obes Metab 2006; 8: 206-213.
    • (2006) Diabetes Obes Metab , vol.8 , pp. 206-213
    • Finer, N.1    Ryan, D.H.2    Renz, C.L.3    Hewkin, A.C.4
  • 13
    • 0004318660 scopus 로고    scopus 로고
    • Obesity: Preventing and managing the global epidemic
    • World Health Organization, Geneva: WHO
    • World Health Organization. Obesity: preventing and managing the global epidemic. Report of WHO consultation on obesity. Geneva: WHO; 1997.
    • (1997) Report of WHO Consultation on Obesity
  • 15
    • 0014895192 scopus 로고
    • Perceived exertion as an indicator of somatic stress
    • Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970; 2: 92-98.
    • (1970) Scand J Rehabil Med , vol.2 , pp. 92-98
    • Borg, G.1
  • 16
    • 0021813187 scopus 로고
    • Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
    • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
    • (1985) Diabetologia , vol.28 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3    Naylor, B.A.4    Treacher, D.F.5    Turner, R.C.6
  • 19
    • 0038359739 scopus 로고    scopus 로고
    • Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans
    • Yannakoulia M, Yiannakouris N, Bluher S, Matalas AL, Klimis-Zacas D, Mantzoros CS. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metabol 2003; 88: 1730-1736.
    • (2003) J Clin Endocrinol Metabol , vol.88 , pp. 1730-1736
    • Yannakoulia, M.1    Yiannakouris, N.2    Bluher, S.3    Matalas, A.L.4    Klimis-Zacas, D.5    Mantzoros, C.S.6
  • 21
    • 0032710356 scopus 로고    scopus 로고
    • Clinical Efficacy of an Automated High-Sensitivity C-Reactive Protein Assay
    • Rifai N, Tracy RP, Ridker PM. Clinical Efficacy of an Automated High-Sensitivity C-Reactive Protein Assay. Clin Chem 1999; 45(12): 2136-2141.
    • (1999) Clin Chem , vol.45 , Issue.12 , pp. 2136-2141
    • Rifai, N.1    Tracy, R.P.2    Ridker, P.M.3
  • 22
    • 0017835519 scopus 로고
    • The glycosylation of haemoglobin. Relevance to diabetes mellitus
    • Bunn HF, Gabbay KH, Gallop PM. The glycosylation of haemoglobin. Relevance to diabetes mellitus. Science 1978; 200: 21-27.
    • (1978) Science , vol.200 , pp. 21-27
    • Bunn, H.F.1    Gabbay, K.H.2    Gallop, P.M.3
  • 23
    • 0032887833 scopus 로고    scopus 로고
    • A desktop guide to type 2 diabetes mellitus
    • European Diabetes Policy Group
    • European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabet Med 1999; 16: 716-730.
    • (1999) Diabet Med , vol.16 , pp. 716-730
  • 24
    • 0015376786 scopus 로고
    • Determination of total serum insulin (IRI) in insulin-treated diabetic patients
    • Heding LG. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972; 8: 260-266.
    • (1972) Diabetologia , vol.8 , pp. 260-266
    • Heding, L.G.1
  • 25
    • 0017358973 scopus 로고
    • Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA II)
    • Klose S, Borner K. Enzymatische Bestimmung des Gesamtcholesterins mit dem Greiner Selective Analyzer (GSA II). J Clin Chem Clin Biochem 1978; 15: 121-130.
    • (1978) J Clin Chem Clin Biochem , vol.15 , pp. 121-130
    • Klose, S.1    Borner, K.2
  • 27
    • 33745026603 scopus 로고
    • The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
    • Havel RJ, Edr HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345-1353.
    • (1955) J Clin Invest , vol.34 , pp. 1345-1353
    • Havel, R.J.1    Edr, H.A.2    Bragdon, J.H.3
  • 28
    • 0015348189 scopus 로고
    • Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge
    • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
    • (1972) Clin Chem , vol.18 , pp. 499-502
    • Friedewald, W.T.1    Levy, R.I.2    Fredrickson, D.S.3
  • 33
    • 71849117083 scopus 로고    scopus 로고
    • Exercise training improved insulin sensitivity and ovarian morphology in rats with polycystic ovary syndrome
    • Qiu S, Wu C, Lin F, Chen L, Huang Z, Jiang Z. Exercise training improved insulin sensitivity and ovarian morphology in rats with polycystic ovary syndrome. Horm Metab Res 2009; 41: 880-885.
    • (2009) Horm Metab Res , vol.41 , pp. 880-885
    • Qiu, S.1    Wu, C.2    Lin, F.3    Chen, L.4    Huang, Z.5    Jiang, Z.6
  • 34
    • 33845479911 scopus 로고    scopus 로고
    • Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes
    • Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, Park KS. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 2006; 29: 2457-2461.
    • (2006) Diabetes Care , vol.29 , pp. 2457-2461
    • Cho, Y.M.1    Youn, B.S.2    Lee, H.3    Lee, N.4    Min, S.S.5    Kwak, S.H.6    Lee, H.K.7    Park, K.S.8
  • 36
    • 4043085036 scopus 로고    scopus 로고
    • Adenovirus-mediated chronic 'hyper-resistinemia' leads to in vivo insulin resistance in normal rats
    • Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I and Olefsky JM. Adenovirus-mediated chronic 'hyper-resistinemia' leads to in vivo insulin resistance in normal rats. J Clin Invest 2004; 114: 224-231.
    • (2004) J Clin Invest , vol.114 , pp. 224-231
    • Satoh, H.1    Nguyen, M.T.2    Miles, P.D.3    Imamura, T.4    Usui, I.5    Olefsky, J.M.6
  • 39
    • 70449720558 scopus 로고    scopus 로고
    • Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diadetes mellitus rats
    • Sharma AK, Srinivasan BP. Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diadetes mellitus rats. Eur J Pharm Sci 2009; 38: 433-444.
    • (2009) Eur J Pharm Sci , vol.38 , pp. 433-444
    • Sharma, A.K.1    Srinivasan, B.P.2
  • 41
    • 12344327355 scopus 로고    scopus 로고
    • Visfatin: A new adipokine
    • Hug C, Lodish HF. Visfatin: a new adipokine. Science 2005; 307: 366-367.
    • (2005) Science , vol.307 , pp. 366-367
    • Hug, C.1    Lodish, H.F.2
  • 42
    • 0035814966 scopus 로고    scopus 로고
    • C-reactive protein-mediated lipoprotein uptake by macrophages
    • Zwacka TP, Hornbach V, Torzewski J. C-reactive protein-mediated lipoprotein uptake by macrophages. Circulation 2001; 103: 1194-1197.
    • (2001) Circulation , vol.103 , pp. 1194-1197
    • Zwacka, T.P.1    Hornbach, V.2    Torzewski, J.3
  • 43
    • 53649101960 scopus 로고    scopus 로고
    • The role of inflammation in vascular insulin resistance with focus on IL-6
    • Andersen K, Pedersen BK. The role of inflammation in vascular insulin resistance with focus on IL-6. Horm Metab Res 2008; 40: 635-639.
    • (2008) Horm Metab Res , vol.40 , pp. 635-639
    • Andersen, K.1    Pedersen, B.K.2
  • 45
    • 8644223451 scopus 로고    scopus 로고
    • Comparison of metabolic effects oforlistat and sibutramine treatment in Type 2 diabetic obese patients
    • Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R. Comparison of metabolic effects oforlistat and sibutramine treatment in Type 2 diabetic obese patients. Diabetes Nutr Metab 2004; 17: 222-229.
    • (2004) Diabetes Nutr Metab , vol.17 , pp. 222-229
    • Derosa, G.1    Cicero, A.F.2    Murdolo, G.3    Ciccarelli, L.4    Fogari, R.5
  • 46
    • 19244366940 scopus 로고    scopus 로고
    • What kind of cardiovascular alterations could be influenced positively by oral antidiabetic agents?
    • Pogátsa G. What kind of cardiovascular alterations could be influenced positively by oral antidiabetic agents? Diabetes Res Clin Pract 1996; 31: S27-31.
    • (1996) Diabetes Res Clin Pract , vol.31
    • Pogátsa, G.1
  • 47
    • 53749096863 scopus 로고    scopus 로고
    • 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
    • Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med 2008; 359 (15): 1577-1589.
    • (2008) N Engl J Med , vol.359 , Issue.15 , pp. 1577-1589
    • Holman, R.R.1    Paul, S.K.2    Bethel, M.A.3    Matthews, D.R.4    Neil, H.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.